Cargando…
A Closed-Loop Autologous Erythrocyte-Mediated Delivery Platform for Diabetic Nephropathy Therapy
Failure to control blood glucose level (BGL) may aggravate oxidative stress and contribute to the development of diabetic nephropathy (DN). Using erythrocytes (ERs) as the carriers, a smart self-regulatory insulin (INS) release system was constructed to release INS according to changes in BGLs to im...
Autores principales: | Feng, Lingzi, Huang, Xinzhong, Li, Jia, Chen, Chao, Ma, Yidan, Gu, Haiying, Hu, Yong, Xia, Donglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612375/ https://www.ncbi.nlm.nih.gov/pubmed/36296745 http://dx.doi.org/10.3390/nano12203556 |
Ejemplares similares
-
Erythrocyte membrane-camouflaged nanoparticles as effective and biocompatible platform: Either autologous or allogeneic erythrocyte-derived
por: Dai, Jun, et al.
Publicado: (2022) -
A Closed-Loop Optogenetic Platform
por: Firfilionis, Dimitrios, et al.
Publicado: (2021) -
CLoSES: A platform for closed-loop intracranial stimulation in humans
por: Zelmann, Rina, et al.
Publicado: (2020) -
Pharmacokinetic Properties of Cytokines in Their Targeted Delivery Based on Autologous Erythrocyte Pharmacocytes
por: Zhumadilov, Zhaxybay, et al.
Publicado: (2014) -
Autologous erythrocytes delivery of berberine hydrochloride with long-acting effect for hypolipidemia treatment
por: Cheng, Zhongyao, et al.
Publicado: (2020)